Background: Sub-Saharan Africa has the highest prevalence of primary open-angle
glaucoma (POAG), at 4.2%. The efficacy of medical treatment has been
demonstrated and remains one of the treatments of choice for POAG. However, in
sub-Saharan Africa, its effectiveness has many challenges, due to multiple
factors, including cost and access to care. Thus, the present study aimed to
determinethe
epidemiological, clinical, therapeutic and evolutive profile of primary
open-angle glaucoma patients. Methodology: A descriptive cross-sectional
study was carried out in two hospitals in western Cameroon. Epidemiological,
clinical, therapeutic, and evolutionary data on intraocular pressure at one
year after medical treatment were analyzed. SPSS version 23 software was used
for statistical analysis, with a significant p-value set at 5%. Results: A total of 201 patients with POAG were included in the study. The population
comprised 100 men and 101 women, with a mean age of 54 ±12 years. At diagnosis,
the mean intraocular pressure was 23.9±8.70
mmHg for the right eye and 25.5±9.57 mmHg for the left
eye. The mean cup/disc ratio was 0.64±0.2
[0.2-1] and 0.67±0.19 [02-1] in the right and left
eyes, respectively. Monotherapy was the most prescribed treatment [59.2%].
After one year of treatment, intraocular pressure was reduced by 15.5% with
beta-blockers, 23.66% with prostaglandins, 19.11%
References
[1]
Flaxman, S.R., Bourne, R.R., Resnikoff, S., Ackland, P., Braithwaite, T., Cicinelli, M. V., et al. (2017) Global Causes of Blindness and Distance Vision Impairment 1990-2020: A Systematic Review and Meta-Analysis. The Lancet Global Health, 5, e1221-e1234. https://doi.org/10.1016/S2214-109X(17)30393-5
[2]
Tham, Y.C., Li, X., Wong, T.Y., Quigley, H.A., Aung, T., Cheng, C.Y. (2014) Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040: A Systematic Review and Meta-Analysis. Ophthalmology, 121, 2081-2090. https://doi.org/10.1016/j.ophtha.2014.05.013
[3]
Ellong, A., Mvogo, C.E., Bella-Hiag, A.L., Mouney, E.N., Ngosso, A. and Litumbe, C.N. (2006) La prévalence des glaucomes dans une population de Noirs camerounais. Cahiers d’études et de recherches francophones/Santé, 16, 83-88.
[4]
Kyari, F.F., Adekoya, B., Abdull, M.M., Mohammed, A.S. and Garba, F. (2018) The Current Status of Glaucoma and Glaucoma Care in Sub-Saharan Africa. Asia-Pacific Journal of Ophthalmology, 7, 375-386.
[5]
Preußner, P.R., Großmann, A., Ngounou, F., Kouogan, G. and Tamon, J. (2009) Glaucoma Screening in Western Cameroon. Graefe’s Archive for Clinical and Experimental Ophthalmology, 247, 1671-1675. https://doi.org/10.1007/s00417-009-1166-7
[6]
Ocular Hypertension Treatment Study Group, European Glaucoma Prevention Study Group, Gordon, M.O., Torri, V., Miglior, S., Beiser, J.A., et al. (2007) Validated Prediction Model for the Development of Primary Open-Angle Glaucoma in Individuals with Ocular Hypertension. Ophthalmology, 114, 10-19. https://doi.org/10.1016/j.ophtha.2006.08.031
[7]
Bertaud, S., Aragno, V., Baudouin, C. and Labbé, A. (2019) Le glaucome primitif à angle ouvert. La Revue de Médecine Interne, 40, 445-452. https://doi.org/10.1016/j.revmed.2018.12.001
[8]
van der Valk, R., Webers, C.A., Schouten, J.S., Zeegers, M.P., Hendrikse, F. and Prins, M.H. (2005) Intraocular Pressure-Lowering Effects of All Commonly Used Glaucoma Drugs: A Meta-Analysis of Randomized Clinical Trials. Ophthalmology, 112, 1177-1185. https://doi.org/10.1016/j.ophtha.2005.01.042
[9]
Domngang, C., Maguib, P., Ngoune, C.N., Foutse, Y. and Kagmeni, G. (2023) Direct Healthcare Cost and Barriers to the Medical Management of Primary Open-Angle Glaucoma in Healthcare Facilities in Yaounde-Cameroon. IHOPE Journal of Ophthalmology, 2, 57-62. https://doi.org/10.25259/IHOPEJO_16_2023
[10]
Mills, R.P., Budenz, D.L., Lee, P.P., Noecker, R.J., Walt, J.G., Siegartel, L.R., et al. (2006) Categorizing the Stage of Glaucoma from Pre-Diagnosis to End-Stage Disease. American Journal of Ophthalmology, 141, 24-30. https://doi.org/10.1016/j.ajo.2005.07.044
[11]
Damji, K.F., Behki, R., Wang, L. and Target IOP Workshop Participants (2003) Canadian Perspectives in Glaucoma Management: Setting Target Intraocular Pressure Range. Canadian Journal of Ophthalmology, 38, 189-197. https://doi.org/10.1016/S0008-4182(03)80060-1
[12]
Eballé, A.O., Owono, D., Bella, A.L., Ebana, C., Lomg, D. and Aboutou, R. (2008) Caractéristiques cliniques et épidémiologiques du glaucome chronique à angle ouvert. Cahiers d’études et de Recherches Francophones/Santé, 18, 251-255. https://doi.org/10.1684/san.2008.0095
[13]
Giles, K., Christelle, D., Georges, N.T. and Wiedemann, P. (2014) Initial Treatment of Glaucoma in a Rural Eye Clinic in Cameroon: Surgery or Medications. https://www.researchgate.net/profile/Peter-Wiedemann-2/publication/268517778_Initial_Treatment_of_Glaucoma_in_a_Rural_Eye_Clinic_in_Cameroon_Surgery_or_Medications/links/5603b98208ae460e2704f450/Initial-Treatment-of-Glaucoma-in-a-Rural-Eye-Clinic-in-Cameroon-Surgery-or-Medications.pdf
[14]
Sounouvou, I., Tchabi, S., Monteiro, S., Yehouessi, L., Doutetien, C. and Bassabi, S.K. (2012) Thérapeutique du glaucome primitif à angle ouvert à Cotonou: à propos de 224 cas. Journal Français d’Ophtalmologie, 35, 100-105. https://doi.org/10.1016/j.jfo.2011.02.015
[15]
Philippin, H., Matayan, E., Knoll, K.M., Macha, E., Mbishi, S., Makupa, A., et al. (2021) Selective Laser Trabeculoplasty versus 0.5% Timolol Eye Drops for the Treatment of Glaucoma in Tanzania: A Randomised Controlled Trial. The Lancet Global Health, 9, e1589-e1599. https://doi.org/10.1016/S2214-109X(21)00348-X
[16]
Diallo, J.W., Ahnoux-Zabsonré, A., Dolo-Traoré, M., Ilboudo, P., Sanou, J. and Méda, N. (2021) Résultats tonométriques préliminaires de la trabéculoplastie sélective au laser (SLT) chez les glaucomateux au Burkina Faso. Journal Français d’Ophtalmologie, 44, 409-414. https://doi.org/10.1016/j.jfo.2020.06.039
